IT1189215B - Procedimento per la produzione di un anticorpo anti-proteina umana - Google Patents

Procedimento per la produzione di un anticorpo anti-proteina umana

Info

Publication number
IT1189215B
IT1189215B IT47705/82A IT4770582A IT1189215B IT 1189215 B IT1189215 B IT 1189215B IT 47705/82 A IT47705/82 A IT 47705/82A IT 4770582 A IT4770582 A IT 4770582A IT 1189215 B IT1189215 B IT 1189215B
Authority
IT
Italy
Prior art keywords
procedure
production
human anti
protein antibody
antibody
Prior art date
Application number
IT47705/82A
Other languages
English (en)
Other versions
IT8247705A0 (it
Inventor
Mitsuhashi Masakazu
Koyama Shunsaku
Original Assignee
Hayashibara Biochem Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Biochem Lab filed Critical Hayashibara Biochem Lab
Publication of IT8247705A0 publication Critical patent/IT8247705A0/it
Application granted granted Critical
Publication of IT1189215B publication Critical patent/IT1189215B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/862—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgE or IgD

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT47705/82A 1981-02-06 1982-02-02 Procedimento per la produzione di un anticorpo anti-proteina umana IT1189215B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56015812A JPS5823847B2 (ja) 1981-02-06 1981-02-06 抗ヒト蛋白質抗体の製造方法

Publications (2)

Publication Number Publication Date
IT8247705A0 IT8247705A0 (it) 1982-02-02
IT1189215B true IT1189215B (it) 1988-01-28

Family

ID=11899249

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47705/82A IT1189215B (it) 1981-02-06 1982-02-02 Procedimento per la produzione di un anticorpo anti-proteina umana

Country Status (7)

Country Link
US (2) US4474756A (it)
JP (1) JPS5823847B2 (it)
KR (1) KR870002162B1 (it)
CH (1) CH650684A5 (it)
FR (1) FR2499414B1 (it)
GB (1) GB2096146B (it)
IT (1) IT1189215B (it)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
EP0084344A3 (en) * 1982-01-14 1983-08-03 Asahi Kasei Kogyo Kabushiki Kaisha Anti-urokinase monoclonal antibodies and process for preparing the same
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
US4693891A (en) * 1985-09-09 1987-09-15 Miles Laboratories, Inc. Vaccine for Pseudomonas aeruginosa
US4707543A (en) * 1985-09-17 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines
FR2593705B1 (fr) * 1986-02-04 1991-07-26 Lafon Labor Composition pour l'interruption de la grossesse comprenant des anticorps monoclonaux reconnaissant l'hormone chorionique gonadotrope ou un peptide de structure analogue, anticorps monoclonaux, procede de production de ces anticorps, hybridomes et procede d'obtention de ces hybridomes
US5449760A (en) * 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
EP0326111A3 (en) * 1988-01-29 1989-12-27 New York Blood Center, Inc. Peptide derivatives rendered immunogenic when administered with alum as an adjuvant
DE3812181A1 (de) * 1988-04-13 1989-10-26 Werner E G Prof Dr Mueller Arzneimittel, enthaltend natuerliche und/oder chemisch modifizierte mono- oder polysaccharide und deren verwendung
JP2896580B2 (ja) * 1989-08-25 1999-05-31 チッソ株式会社 アミロース―リゾチームハイブリッドと活性化糖およびその製造法
US5242686A (en) * 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
US6004563A (en) * 1990-11-07 1999-12-21 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
ATE158172T1 (de) * 1992-05-26 1997-10-15 Procter & Gamble Pulverförmige pharmazeutische zusammensetzung
US5912000A (en) * 1994-09-23 1999-06-15 Zonagen, Inc. Chitosan induced immunopotentiation
WO1996009805A2 (en) * 1994-09-23 1996-04-04 Zonagen, Inc. Chitosan induced immunopotentiation
US5980912A (en) * 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
US5960824A (en) * 1998-06-01 1999-10-05 Ford Motor Company Scroll compressor having contoured fixed rotation suction control valve
US6280742B1 (en) 1998-06-17 2001-08-28 Zonagen, Inc. Methods and materials for the treatment of prostatic carcinoma
EP1113814A1 (en) * 1998-09-17 2001-07-11 Zonagen, Inc. Human chorionic gonadotropin vaccines
US7541159B2 (en) * 2004-04-14 2009-06-02 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Molecular-specific urokinase antibodies
WO2012095746A2 (en) 2011-01-11 2012-07-19 Capsugel Belgium Nv New hard capsules
CA3059529A1 (en) 2017-04-14 2018-10-18 Capsugel Belgium Nv Process for making pullulan
CN110678170A (zh) 2017-04-14 2020-01-10 比利时胶囊公司 普鲁兰多糖胶囊

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758425A (fr) * 1969-12-02 1971-04-16 Baxter Laboratories Inc Streptokinase liee chimiquement a une matrice en carbohydrate (
US4185090A (en) * 1972-02-02 1980-01-22 Abbott Laboratories Chemically modified endotoxin immunizing agent
FR2244543B1 (it) * 1973-07-27 1977-07-01 Inst Nl Sante Rech Medica
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
FR2319379A1 (fr) * 1975-07-29 1977-02-25 All India Inst Medical Scie Vaccin contre la gravidite et procede de sa preparation
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
JPS5639022A (en) * 1979-09-05 1981-04-14 Hayashibara Biochem Lab Inc Preparation of vaccine
US4364935A (en) * 1979-12-04 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human prothymocyte antigen and methods of preparing same

Also Published As

Publication number Publication date
GB2096146B (en) 1984-08-08
IT8247705A0 (it) 1982-02-02
US4474756A (en) 1984-10-02
JPS5823847B2 (ja) 1983-05-18
CH650684A5 (fr) 1985-08-15
FR2499414B1 (fr) 1985-10-25
KR830008685A (ko) 1983-12-14
GB2096146A (en) 1982-10-13
JPS57130922A (en) 1982-08-13
FR2499414A1 (fr) 1982-08-13
US4814169A (en) 1989-03-21
KR870002162B1 (ko) 1987-12-14

Similar Documents

Publication Publication Date Title
IT1189215B (it) Procedimento per la produzione di un anticorpo anti-proteina umana
IT1171469B (it) Procedimento per la produzione di eritropoietina umana
IT1160468B (it) Procedimento per la produzione di anticorpi monoclonali umani
IT1175917B (it) Procedimento per la fabbricazione di un dispositivo microminiatura
RO87590A (ro) Procedeu de preparare a interferenului de leucocita umana matura
IT1152146B (it) Procedimento per la produzione di nerofumo
ES503273A0 (es) Un procedimiento de preparacion de un modificador de reolo- gia de uretano
IT1142165B (it) Procedimento per la produzione di acciai inossidabili
IT8149118A0 (it) Procedimento per la produzionedi gonadotropina coriale umana
IT1142943B (it) Procedimento per la produzione di urochinasi umana
IT1154275B (it) Procedimento per la produzione di disolfuri di tiurame
IT1144744B (it) Procedimento per la produzione di solfobetaine
IT1154271B (it) Procedimento per la produzione di disolfuri di tiurama sostituiti
IT1154263B (it) Massa di annegamento poliuretanica e procedimento per la sua produzione
AR229034A1 (es) Procedimiento para la preparacion de un polipeptido
IT1196534B (it) Procedimento per la produzione di insulina umana
IT1209875B (it) Procedimento per la produzione di 2-metilenaldeidi
IT1148020B (it) Procedimento per la produzione di calcitonina umana
IT1170744B (it) Procedimento per la produzione di o-trimetil-sililcellulose
IT1143224B (it) Procedimento per la produzione di prolattina umana
IT1144700B (it) Procedimento per la preparazione di un derivato della glicina
IT1172155B (it) Procedimento per la produzione di agenti di carbocementazione
IT1149744B (it) 1-pirazolil fosfito e procedimento per la sua produzione
IT1140310B (it) Procedimento per la preparazione di intermedi per piretroidi
IT1190971B (it) Procedimento per la produzione di 2-ammino-4-idrossi-5-alogeno-pirimidine

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960221